Grape powder may boost gut health in obesity, small study hopes
NCT ID NCT07231484
First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 3 times
Summary
This study tests whether eating freeze-dried grape powder every day for 4 weeks can improve gut bacteria, reduce inflammation, and lower stress in adults with obesity. Fifty participants aged 30-45 will be randomly assigned to receive grape powder or a placebo, then switch after a break. Researchers will measure changes in gut microbes, immune markers, and body composition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- freeze-dried grape powder
- What this could lead to
- If it works, this could point toward a simple dietary addition to help manage obesity-related inflammation and gut health.
- What could go wrong
- This is a small, early-stage trial with only 50 participants. The effects may be modest or not translate to real-world grape consumption. No major risks expected, but benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Missouri-Columbia
RECRUITINGColumbia, Missouri, 65211, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Low-Calorie diet and Weight-Loss drug send type 2 diabetes into remission?
- Pedal-Assist E-Bikes may boost fitness and cut fat in sedentary students
- New program helps seniors in camden fight obesity and pain without drugs
- Exercise boosts Weight-Loss surgery results, study finds
- Obesity drug VCT220 put to the test: will common meds interfere?
- New obesity drug VCT220 put through drug interaction tests